Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival.
Karnitz LM, Flatten KS, Wagner JM, Loegering D, Hackbarth JS, Arlander SJ, Vroman BT, Thomas MB, Baek YU, Hopkins KM, Lieberman HB, Chen J, Cliby WA, Kaufmann SH.
Karnitz LM, et al. Among authors: lieberman hb.
Mol Pharmacol. 2005 Dec;68(6):1636-44. doi: 10.1124/mol.105.012716. Epub 2005 Aug 26.
Mol Pharmacol. 2005.
PMID: 16126823